NT5DC2 downregulation suppresses monoamine oxidase activity and increases catecholamine levels in PC12D cells
Back ground Genome-wide association studies have revealed the involvement of 5'-nucleotidase domain-containing protein 2 (NT5DC2) in neuropsychiatric disorders such as schizophrenia and bipolar disorder; however, its function remains unclear. Recently, we found that NT5DC2 downregulation in PC12D cells increases catecholamine synthesis by promoting the activity of tyrosine hydroxylase and that monoamine oxidase A (MAO A) might bind to NT5DC2 using Affinity Purification-Mass Spectroscopy. Methods and Results We investigated the role of NT5DC2 for MAO A activity in PC12D cells. Western blot analysis revealed that NT5DC2 primarily binds to the non-phosphorylated form of MAO A. siRNA-mediated NT5DC2 downregulation reduced MAO A activity, leading to decreased dopamine metabolism and increased noradrenaline synthesis. Conclusion Our findings suggest that NT5DC2 could affect both tyrosine hydroxylase and MAO A activity to control catecholamine synthesis. Therefore, our study provides valuable insights into disorders associated with catecholamine dysregulation, such as Parkinson's disease and neuropsychiatric disorders.